ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Nurse Practitioner

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,596Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 150

$883K Total Retail Price of All Prescriptions

Rank: 5 out of 150

530 Patients Receiving at Least One Drug in Part D
77% Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Louisiana
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 530 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $76 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 518 410 70 1 4
SIMVASTATIN 381 314 63 2 9
AMLODIPINE BESYLATE 323 276 54 3 1
OMEPRAZOLE 276 155 43 4 11
FUROSEMIDE 267 201 51 5 6
TRAMADOL HCL-ACETAMINOPHEN 229 190 47 6 88
HYDROCODONE-ACETAMINOPHEN 221 147 56 S3 7 10
CRESTOR 216 151 29 8 24
METFORMIN HCL 204 161 29 9 5
AZITHROMYCIN 203 152 148 10 26
CARVEDILOL 193 177 32 11 15
ALENDRONATE SODIUM 185 154 34 12 64
SPIRIVA 180 133 30 13 56
ATORVASTATIN CALCIUM 164 112 26 14 3
HYDROCHLOROTHIAZIDE 161 156* 28 15 13
CLOPIDOGREL 153 136 21 16 7
LISINOPRIL 146 81 35 17 2
MONTELUKAST SODIUM 143 115 21 18 32
MELOXICAM 140 115 32 19 18
AMITRIPTYLINE HCL 132 127* 22 R 20 44
LOSARTAN POTASSIUM 129 124* 19 21 22
NEXIUM 126 67 24 22 21
DIOVAN 123 118* 19 23 35
WARFARIN SODIUM 121 93 17 24 23
VALSARTAN-HYDROCHLOROTHIAZIDE 110 105* 16 25 49
ESCITALOPRAM OXALATE 108 44 22 26 42
CLONAZEPAM 103 71 19 B 27 38
GLIMEPIRIDE 101 96* 14 28 28
SULFAMETHOXAZOLE-TRIMETHOPRIM 100 68 75 29 67
JANUVIA 98 50 15 30 54
SYNTHROID 97 79 16 31 78
ALPRAZOLAM 94 83 25 B 32 20
POTASSIUM CHLORIDE 93 63 18 33 19
DONEPEZIL HCL 93 80 14 33 76
GABAPENTIN 93 62 15 33 17
SERTRALINE HCL 92 46 18 36 37
CITALOPRAM HBR 89 76 21 37 29
METOPROLOL TARTRATE 88 83* 18 38 12
LOVASTATIN 87 54 13 39 48
ADVAIR DISKUS 87 61 18 39 58
TRADJENTA 86 <11 <11 41 133
METOPROLOL SUCCINATE 80 46 13 42 14
PROAIR HFA 78 59 16 43 31
LOSARTAN-HYDROCHLOROTHIAZIDE 76 71* 13 44 40
TEMAZEPAM 76 59 11 B 44 162
ATENOLOL 71 66* 12 46 36
FENOFIBRATE* 70 27 12 47 53
AMLODIPINE BESYLATE-BENAZEPRIL 67 <11 <11 48 61
AMITIZA 65 <11 <11 49 177
CYCLOBENZAPRINE HCL 64 30 24 R 50 71
ALLOPURINOL 62 57* 11 51 46
NATEGLINIDE 61 <11 <11 52 186
BYSTOLIC 60 34 11 53 91
RAMIPRIL 59 <11 <11 54 68
COLCRYS 58 44 12 55 124
PIOGLITAZONE HCL 57 <11 <11 R 56 109
PRAVASTATIN SODIUM 56 51* 12 57 8
METHYLPREDNISOLONE 56 51* 42 57 41
DEXILANT 54 27 11 59 124
LANTUS SOLOSTAR 53 48* 12 60 59
CYMBALTA 53 <11 <11 60 47
CLOTRIMAZOLE-BETAMETHASONE 51 31 22 62 203
ZOLPIDEM TARTRATE 51 46* 15 62 30
CELEBREX 51 40 16 62 123
NAMENDA 51 <11 <11 62 85
FLUTICASONE PROPIONATE 50 50 14 66 27
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.